27871915|t|Inhibition of siglec-1 by lentivirus mediated small interfering RNA attenuates atherogenesis in apoE - deficient mice
27871915|a|Siglec-1 is highly expressed on circulating monocytes and plaque macrophages in atherosclerotic patients, but the exact role of Siglec-1 in atherosclerosis has not been elucidated. Lentiviral vector containing small interfering RNA targeting Siglec-1 (Lv-shSiglec-1) or control vector (Lv-shNC) were injected intravenously into 6- week old Apoe(-/-) mice. Then onset of atherosclerosis was observed. Siglec-1 was highly expressed in aortic plaques and it can be down-regulated by Lv-shSiglec-1 injection. The plaque area and serum pro-inflammatory cytokine (IL-1β, IL-6, TNF-α and IL-17A) levels in Lv-shSiglec-1 mice were significantly lower than Lv-shNC mice, whereas IL-10 was higher. Moreover, plaque macrophages accumulation in aortic wall in Lv-shSiglec-1 mice was diminish, partly by decreased secretion of MCP-1 / CXCL2 and CCR2 / CXCR2 of aortas and monocytes, respectively. Furthermore, silencing of Siglec-1 can attenuate oxLDL uptake by peritoneal macrophages. Inhibition of Siglec-1 can prevent atherosclerotic lesion formation by suppress monocytes - endothelial cells adhesion and macrophages accumulation.
27871915	0	10	Inhibition	T052	C3463820
27871915	14	22	siglec-1	T028	C1420266
27871915	26	36	lentivirus	T005	C0079679
27871915	46	67	small interfering RNA	T114,T123	C1099354
27871915	68	78	attenuates	T052	C0599946
27871915	79	92	atherogenesis	T046	C1563937
27871915	96	100	apoE	T028	C1412481
27871915	103	117	deficient mice	T015	C0206745
27871915	118	126	Siglec-1	T116,T129,T192	C0142251
27871915	137	146	expressed	T045	C1171362
27871915	150	161	circulating	T169	C0175630
27871915	162	171	monocytes	T025	C0026473
27871915	176	182	plaque	T033	C0332461
27871915	183	194	macrophages	T025	C0024432
27871915	198	213	atherosclerotic	T047	C0004153
27871915	214	222	patients	T101	C0030705
27871915	246	254	Siglec-1	T116,T129,T192	C0142251
27871915	258	273	atherosclerosis	T047	C0004153
27871915	299	316	Lentiviral vector	T121	C1520007
27871915	328	349	small interfering RNA	T114,T123	C1099354
27871915	360	368	Siglec-1	T028	C1420266
27871915	370	383	Lv-shSiglec-1	T121	C1520007
27871915	388	402	control vector	T121	C1520007
27871915	404	411	Lv-shNC	T121	C1520007
27871915	427	440	intravenously	T082	C0013125
27871915	449	453	week	T079	C0439230
27871915	458	467	Apoe(-/-)	T028	C1412481
27871915	468	472	mice	T015	C0206745
27871915	488	503	atherosclerosis	T047	C0004153
27871915	518	526	Siglec-1	T116,T129,T192	C0142251
27871915	538	547	expressed	T045	C1171362
27871915	551	557	aortic	T023	C0003483
27871915	558	565	plaques	T033	C0332461
27871915	580	594	down-regulated	T044	C0013081
27871915	598	611	Lv-shSiglec-1	T121	C1520007
27871915	612	621	injection	T122	C1272883
27871915	627	633	plaque	T033	C0332461
27871915	634	638	area	T082	C0205146
27871915	643	648	serum	T031	C0229671
27871915	649	674	pro-inflammatory cytokine	T116,T129	C0079189
27871915	676	681	IL-1β	T116,T129	C0021753
27871915	683	687	IL-6	T116,T129	C0021760
27871915	689	694	TNF-α	T116,T129	C1456820
27871915	699	705	IL-17A	T116,T192	C1705947
27871915	717	730	Lv-shSiglec-1	T121	C1520007
27871915	731	735	mice	T015	C0025929
27871915	741	760	significantly lower	T081	C4055638
27871915	766	773	Lv-shNC	T121	C1520007
27871915	774	778	mice	T015	C0025929
27871915	788	793	IL-10	T116,T129	C0085295
27871915	816	822	plaque	T033	C0332461
27871915	823	834	macrophages	T025	C0024432
27871915	835	847	accumulation	T033	C4055506
27871915	851	862	aortic wall	T023	C0507851
27871915	866	879	Lv-shSiglec-1	T121	C1520007
27871915	880	884	mice	T015	C0025929
27871915	889	897	diminish	T081	C0205216
27871915	909	918	decreased	T081	C0205216
27871915	919	928	secretion	T038	C0036536
27871915	932	937	MCP-1	T116,T129	C0128897
27871915	940	945	CXCL2	T116	C0912510
27871915	950	954	CCR2	T116,T192	C1670098
27871915	957	962	CXCR2	T116,T129,T192	C0527994
27871915	966	972	aortas	T023	C0003483
27871915	977	986	monocytes	T025	C0026473
27871915	1015	1024	silencing	T045	C0598496
27871915	1028	1036	Siglec-1	T028	C1420266
27871915	1041	1050	attenuate	T052	C0599946
27871915	1051	1056	oxLDL	T116,T123	C0348035
27871915	1057	1063	uptake	T039	C0243144
27871915	1067	1077	peritoneal	T029	C0442034
27871915	1078	1089	macrophages	T025	C0024432
27871915	1091	1101	Inhibition	T052	C3463820
27871915	1105	1113	Siglec-1	T028	C1420266
27871915	1118	1125	prevent	T080	C2700409
27871915	1126	1141	atherosclerotic	T169	C0333482
27871915	1142	1148	lesion	T033	C0221198
27871915	1149	1158	formation	T169	C1522492
27871915	1162	1170	suppress	T169	C1260953
27871915	1171	1180	monocytes	T025	C0026473
27871915	1183	1200	endothelial cells	T025	C0225336
27871915	1201	1209	adhesion	T043	C0007577
27871915	1214	1225	macrophages	T025	C0024432
27871915	1226	1238	accumulation	T033	C4055506